GFACX
Price
$70.77
Change
+$0.82 (+1.17%)
Updated
Jul 31 closing price
Net Assets
356.86B
LDVCX
Price
$22.42
Change
+$0.14 (+0.63%)
Updated
Jul 31 closing price
Net Assets
73.3M
Interact to see
Advertisement

GFACX vs LDVCX

GFACX vs LDVCX Comparison Chart in %
View a ticker or compare two or three
VS
GFACX vs. LDVCX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a StrongBuy and LDVCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 357B vs. LDVCX (73.3M). GFACX (0.00) and LDVCX (0.00) have matching dividends . GFACX was incepted earlier than LDVCX: GFACX (25 years) vs LDVCX (11 years). LDVCX (2.71) is less costly to investors than GFACX (1.35). LDVCX is a more actively managed with annual turnover of: 38.00 vs. GFACX (32.00). GFACX has a lower initial minimum investment than LDVCX: GFACX (250) vs LDVCX (2500). GFACX annual gain was more profitable for investors over the last year : -0.98 vs. LDVCX (-17.48). GFACX return over 5 years is better than : 3.92 vs. LDVCX (-31.20).
GFACXLDVCXGFACX / LDVCX
Total Expense Ratio1.352.5154%
Annual Report Gross Expense Ratio1.352.7150%
Fund Existence25 years11 years-
Gain YTD5.156-13.436-38%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets357B73.3M487,040%
Annual Yield % from dividends0.000.00-
Returns for 1 year-0.98-17.486%
Returns for 3 years27.7435.9677%
Returns for 5 years3.92-31.20-13%
Returns for 10 years76.09123.3762%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BIAFX45.960.66
+1.46%
Brown Advisory Flexible Equity Inv
WFTIX11.650.05
+0.43%
Allspring Innovation Fund - Class Inst
SOAAX8.99-0.02
-0.22%
Spirit of America Real Estate Inc & Gr A
BIIEX30.70-0.18
-0.58%
Brandes International Equity I
MRSJX29.37-0.17
-0.58%
MFS Research International R4